Hematology NewsLess than half of office visits involve primary careAugust 4, 2017Practice ManagementBusiness of Medicine
Oncology PracticeFDA approves dabrafenib and trametinib for BRAF V600E+ metastatic NSCLCJune 23, 2017Lung Cancer
Oncology PracticeFDA approves pembrolizumab for first-line advanced NSCLCMay 12, 2017Lung CancerImmunotherapyImmuno-oncology
Oncology PracticeFDA approves brigatinib for second-line advanced ALK-positive NSCLCApril 28, 2017Lung Cancer
Hematology NewsFDA approves midostaurin for adult patients with FLT3+ AMLApril 28, 2017AMLLeukemia, Myelodysplasia, Transplantation
Oncology PracticeOsimertinib receives full approval for advanced EGFR-mutated NSCLCMarch 31, 2017Lung Cancer
Hematology NewsFDA grants Hodgkin lymphoma indication for pembrolizumabMarch 15, 2017Aggressive LymphomasLymphoma & Plasma Cell Disorders
Hematology NewsMultiple myeloma: Lenalidomide approved as maintenance therapy after auto-HSCTFebruary 22, 2017Multiple MyelomaLymphoma & Plasma Cell Disorders
Oncology PracticeFDA approves nivolumab for advanced urothelial carcinomaFebruary 2, 2017Genitourinary Cancer
Hematology NewsFDA approves ibrutinib for refractory MZLJanuary 19, 2017Indolent LymphomaLeukemia, Myelodysplasia, Transplantation
Hematology NewsFewer people having problems with medical billsJanuary 6, 2017Practice ManagementBusiness of Medicine
Oncology PracticeFDA approves rucaparib for BRCA-positive advanced ovarian cancerDecember 19, 2016Gynecologic Cancer
